Company Market Research Report
Company Overview
Name, Mission of the Company
- Name: PetVivo Holdings, Inc.
- Mission: Advancing animal health through innovation by manufacturing, commercializing, and licensing innovative medical devices and therapeutics for companion animals.
Founding Details
- Year Founded: Data not explicitly available
- Founder(s): Data not explicitly available
Key People
- John Lai: CEO, President & Director
- Garry Lowenthal: Chief Financial Officer
- Randall Meyer: Chief Operating Officer
- John Dolan: Chief Business Development Officer & General Counsel
- April Boyce: Vice President of Marketing
- Josh Wilhelm: Vice President of R&D & Clinical Trials
- Bryan Monninger: Vice President of Sales
Headquarters
- Location: Data not explicitly available
Number of Employees
- Employees: Data not explicitly available
Revenue
- Revenue: Positioned to generate up to $100M in revenue, based on production capacity insights. Specific current revenue figures are not available.
Company Expertise
- Notable For: Known for innovative veterinary medical devices, such as Spryng™ with OsteoCushion™ Technology, and adapting human biotech technologies for the veterinary market.
Products
Product: Spryng™ with OsteoCushion™ Technology
- Description: An intra-articular injectable veterinary medical device designed to address the root cause of lameness issues – missing and/or damaged cartilage in companion animals.
- Key Features: Utilizes proprietary, patented micro-cushion technology to aid in management of lameness, joint pain, and osteoarthritis (OA) in companion animals.
Recent Developments
New Product Launches
- Spryng™ with OsteoCushion™ Technology: Launched as a commercial product to manage lameness issues, joint pain, and osteoarthritis in animals.
Recent Events and Participations
- October 2024: Participated in Spartan Capital Investor Conference and the American College of Veterinary Surgeons Surgery Summit.
- September 2024: Exhibited at the PNWVC and Southwest Veterinary Symposium.
- Previous Key Events: Engaged in TEVA Summer CE Symposium, IVAPM Pain Management Forum, and ACVSMR Symposium.
Strategic Appointments and Hires
- Recent Appointments: Hiring of multiple Regional Business Development Managers and a Senior Technical Services Veterinarian to expand adoption and meet growing demand for Spryng™ technology.
- Notable Hires: Bryan Monninger as VP of Sales, April Boyce as VP of Marketing, and Garry Lowenthal as CFO.
Partnerships & Collaborations
- Partnerships: No specific new partnerships mentioned beyond conference participations and industry collaborations.
Intellectual Property and Pipeline
- Patents: Holds a portfolio of 19 patents and 8 pending applications covering biomaterials, product production processes, and methods of use.
- Product Pipeline: A robust pipeline of 17 products is at various stages of development and commercialization, focusing primarily on veterinary medical devices that do not require FDA premarket approval.
This report provides an encapsulated view of PetVivo Holdings, Inc., focusing on their leadership, product focus, recent strategic developments, and market positioning in the veterinary biotech landscape.
